Diabetic Retinopathy
522
47
65
286
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
56 trials with published results (11%)
Research Maturity
286 completed trials (55% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.1%
32 terminated out of 522 trials
89.9%
+3.4% vs benchmark
16%
81 trials in Phase 3/4
20%
56 of 286 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 286 completed trials
Clinical Trials (522)
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
Village-Integrated Eye Worker Trial II
Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic Retinopathy
Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy
National Eye Institute Biorepository for Retinal Diseases
A Study of PER-001 in Participants With Diabetic Retinopathy
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
Community-Based Eye Screening With Structured Referral Tracking for Preventing Avoidable Blindness in Adults in Rawalpindi, Pakistan
Pre-operative Vabysmo in Patients With Non-clearing Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy
AI-Assisted Detection of Posterior Segment Diseases: DR, AMD, RVO, and Glaucoma
Eye Health Intervention Study in Upper Manhattan
MONITORING OF MODERATE DIABETIC RETINOPATHY BY TELE-EXPERTISE
Assessment of Retinal-Angio Findings In Patients With Diabetes Type II Treated With Novel Antidiabetic Therapies
I-TRUST: Implementation of Teleophthalmology in Rural Health Systems Study
Video-based Patient Education Intervention for Diabetic Eye Screening in Latinx Communities
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic Retinopathy
A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR)
Retinal Ischemia Characterization in Diabetes - "RICHARD"
Village-Integrated Eye Worker Trial II - Pilot
Effect of Omega-3 Fatty Acids on Eye Blood Vessels in Type 1 Diabetes